{"transactions":[{"id":1900841,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-09T01:53:37.000Z","date":"2023-04-25","kind":"grant","planned":false,"acquired":true,"shares":49200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, April 25, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's eighth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":49200,"derivative":{"exercise_price":5.59,"expiration_date":"2033-04-24","underlying":"Common Stock","underlying_shares":49200},"source":{"system":"sec-edgar","filing":"0001437749-23-013125","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923013125/rdgdoc.xml","form_type":"4"}},{"id":1956649,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-13T11:59:03.000Z","date":"2023-03-09","kind":"purchase","acquired":true,"shares":11000,"price":4.1953,"value":46148.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1166 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":18500,"source":{"system":"sec-edgar","filing":"0001437749-23-006280","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774923006280/rdgdoc.xml","form_type":"4"}},{"id":2218637,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-30T21:19:32.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, June 28, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.52,"expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-22-016301","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922016301/rdgdoc.xml","form_type":"4"}},{"id":2265539,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-18T23:01:34.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":339,"price":4.97,"value":1684.83,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001437749-22-012945","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922012945/rdgdoc.xml","form_type":"4"}},{"id":2265538,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-18T23:01:34.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":3051,"price":4.96,"value":15132.96,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":7161,"source":{"system":"sec-edgar","filing":"0001437749-22-012945","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922012945/rdgdoc.xml","form_type":"4"}},{"id":2265537,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-18T23:01:34.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":915,"price":4.95,"value":4529.25,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":4110,"source":{"system":"sec-edgar","filing":"0001437749-22-012945","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922012945/rdgdoc.xml","form_type":"4"}},{"id":2265536,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-18T23:01:34.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":695,"price":4.94,"value":3433.3,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":3195,"source":{"system":"sec-edgar","filing":"0001437749-22-012945","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774922012945/rdgdoc.xml","form_type":"4"}},{"id":2490476,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-01T21:28:32.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":2500,"price":8.44,"value":21100.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001437749-21-027630","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921027630/rdgdoc.xml","form_type":"4"}},{"id":2660761,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T12:35:34.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 17, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's sixth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":15.47,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-21-015181","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774921015181/rdgdoc.xml","form_type":"4"}},{"id":3103028,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-06-23T00:43:33.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the OTCQB Venture Market on the date of grant, June 19, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's fourth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0.271,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-20-013589","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774920013589/rdgdoc.xml","form_type":"4"}},{"id":3471087,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-07-02T21:03:59.000Z","date":"2019-06-30","kind":"grant","acquired":true,"shares":7857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a fully vested restricted stock award (\"RSA\") under the Issuer's 2014 Equity Incentive Plan. The RSA was granted to the Reporting Person in lieu of the quarterly cash compensation payable to the Reporting Person pursuant to the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":24512,"source":{"system":"sec-edgar","filing":"0001437749-19-013391","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919013391/rdgdoc.xml","form_type":"4"}},{"id":3527554,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-15T00:38:54.000Z","date":"2019-05-10","kind":"grant","acquired":true,"shares":8487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a fully vested restricted stock award (\"RSA\") under the Issuer's 2014 Equity Incentive Plan. The RSA was granted to the Reporting Person in lieu of the quarterly cash compensation payable to the Reporting Person pursuant to the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy."}],"balance_after":16655,"source":{"system":"sec-edgar","filing":"0001437749-19-009880","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919009880/rdgdoc.xml","form_type":"4"}},{"id":3547573,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-04-26T21:01:02.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Market on the date of grant, April 24, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's third amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.62,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-19-008064","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774919008064/rdgdoc.xml","form_type":"4"}},{"id":3918539,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-05-24T20:04:52.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Market on the date of grant, May 22, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":6.1,"expiration_date":"2028-05-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-18-010651","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774918010651/rdgdoc.xml","form_type":"4"}},{"id":4306366,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":113757,"kind":"person","name":"Plooster Matthew R","position":1,"cik":"0001638364","reported_name":"Plooster Matthew R","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-05-24T21:30:04.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Market on the date of grant, May 23, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.95,"expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-17-010009","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434647/000143774917010009/rdgdoc.xml","form_type":"4"}}]}